Head / Neck Cancer

High-Risk

  • RTOG 1216– A Phase II/III Randomized Study of Surgery and Postoperative Radiation Delivered with Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck

LOCALLY ADVANCED

  • RTOG 0920 – A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck

METASTATIC

  • RTOG 0631– A Phase II/III Randomized Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis